5 Biotech companies backed by Alexandria Venture Investments, including Avalo, ARTBIO, Dualitas Therapeutics — with the co-investors on each cap table.
Alexandria Venture Investments — Biotech accounts for 26 tracked companies with verified cap-table data, 26 of which disclose round sizes totalling $4.2B. The median disclosed raise is $150M, and the largest is TORL BioTherapeutics at $450M, ahead of Vividion Therapeutics ($362M) and Triveni Bio ($277M).
The names that recur most often on these portfolio cap tables are Alexandria Venture Investments (26 companies), ARCH Venture Partners (4 companies), Nextech Invest (4 companies), Casdin Capital (4 companies), Janus Henderson Investors (4 companies), Atlas Venture (4 companies). By latest disclosed round, the market skews Series A (12), Series B (8), Series C (4), Series D (1).
Companies tracked: 26
Disclosed funding total: $4.2B across 26 companies
Median disclosed raise: $150M
Largest raise: TORL BioTherapeutics — $450M
Stage mix: Series A 12 · Series B 8 · Series C 4 · Series D 1
Most recent dated round: 2026-06-10
Best funded Alexandria Venture Investments — Biotech companies
